Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Bolejack · SciRah

Researcher profile · Semantic Scholar

V. Bolejack

Share profile

V. Bolejack — researcher profile on SciRah

h-index: 35
Works: 75
Citations: 13K

Most-cited papers

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer
P. Goldstraw, K. Chansky, J. Crowley, Ramón Rami-Porta +140 more
2016Journal of Thoracic Oncology4,241 citations Open access
Semantic Scholar
B cells are associated with survival and immunotherapy response in sarcoma
F. Petitprez, A. de Reyniès, Emily Z. Keung, T. Chen +25 more
2020Nature1,713 citations Open access
Semantic Scholar
Pembrolizumab in Advanced Soft Tissue and Bone Sarcomas: Results of SARC028, A Multicentre, Single arm, Phase 2 Trial
H. Tawbi, M. Burgess, V. Bolejack, B. A. Van Tine +20 more
2017The Lancet Oncology1,181 citations Open access
Semantic Scholar
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
R. Rami-Porta, V. Bolejack, J. Crowley, D. Ball +7 more
2007Journal of Thoracic Oncology1,092 citations Open access
Semantic Scholar
The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
P. Groome, V. Bolejack, J. Crowley, C. Kennedy +3 more
2007Journal of Thoracic Oncology612 citations Open access
Semantic Scholar
The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer
K. Chansky, F. Detterbeck, A. Nicholson, V. Rusch +10 more
2017Journal of Thoracic Oncology444 citations Open access
Semantic Scholar
Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3
B. Barlogie, E. Anaissie, F. van Rhee, J. Haessler +16 more
2007British Journal of Haematology334 citations Open access
Semantic Scholar
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer
R. Rami-Porta, V. Bolejack, D. Giroux, K. Chansky +3 more
2014Journal of Thoracic Oncology332 citations Open access
Semantic Scholar
The IASLC Lung Cancer Staging Project: Methodology and Validation Used in the Development of Proposals for Revision of the Stage Classification of NSCLC in the Forthcoming (Eighth) Edition of the TNM Classification of Lung Cancer
F. Detterbeck, K. Chansky, P. Groome, V. Bolejack +6 more
2016Journal of Thoracic Oncology237 citations Open access
Semantic Scholar
Randomized Double-Blind Phase II Study of Regorafenib in Patients With Metastatic Osteosarcoma
Lara E. Davis, V. Bolejack, C. Ryan, K. Ganjoo +13 more
2019Journal of Clinical Oncology220 citations
Semantic Scholar
The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification
F. Detterbeck, A. Nicholson, W. Franklin, E. Marom +11 more
2016Journal of Thoracic Oncology219 citations Open access
Semantic Scholar
Lenalidomide and high-dose dexamethasone compared with dexamethasone as initial therapy for multiple myeloma: a randomized Southwest Oncology Group trial (S0232).
J. Zonder, J. Crowley, M. Hussein, V. Bolejack +5 more
2010Blood204 citations Open access
Semantic Scholar
High serum-free light chain levels and their rapid reduction in response to therapy define an aggressive multiple myeloma subtype with poor prognosis.
F. van Rhee, V. Bolejack, K. Hollmig, M. Pineda‐Roman +10 more
2007Blood191 citations Open access
Semantic Scholar
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab
Emily Z. Keung, M. Burgess, R. Salazar, E. Parra +19 more
2020Clinical Cancer Research186 citations Open access
Semantic Scholar
Long‐term outcome results of the first tandem autotransplant trial for multiple myeloma
B. Barlogie, G. Tricot, F. van Rhee, E. Angtuaco +18 more
2006British Journal of Haematology179 citations
Semantic Scholar
Survival and years of life lost in different age cohorts of patients with multiple myeloma.
H. Ludwig, V. Bolejack, J. Crowley, J. Bladé +16 more
2010Journal of Clinical Oncology168 citations Open access
Semantic Scholar
Phase 2 study of dasatinib in patients with alveolar soft part sarcoma, chondrosarcoma, chordoma, epithelioid sarcoma, or solitary fibrous tumor
S. Schuetze, V. Bolejack, E. Choy, K. Ganjoo +16 more
2017Cancer133 citations Open access
Semantic Scholar
Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts.
M. Burgess, V. Bolejack, S. Schuetze, B. Van Tine +16 more
2019Journal of Clinical Oncology118 citations
Semantic Scholar
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer.
S. Denmeade, Hao Wang, N. Agarwal, David C. Smith +24 more
2021Journal of Clinical Oncology116 citations Open access
Semantic Scholar
The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer
F. Detterbeck, V. Bolejack, D. Arenberg, J. Crowley +11 more
2016Journal of Thoracic Oncology105 citations Open access
Semantic Scholar
Occupational Exposure to Solvents and the Risk of Lymphomas
L. Miligi, A. S. Costantini, A. Benvenuti, D. Kriebel +16 more
2006Epidemiology95 citations Open access
Semantic Scholar
Superiority of Lenalidomide (Len) Plus High-Dose Dexamethasone (HD) Compared to HD Alone as Treatment of Newly-Diagnosed Multiple Myeloma (NDMM): Results of the Randomized, Double-Blinded, Placebo-Controlled SWOG Trial S0232.
J. Zonder, J. Crowley, M. Hussein, V. Bolejack +5 more
200789 citations
Semantic Scholar
A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas
A. Pappo, Gilles Vassal, J. Crowley, V. Bolejack +16 more
2014Cancer75 citations Open access
Semantic Scholar
Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group.
Heinz Ludwig, B. Durie, V. Bolejack, I. Turesson +19 more
2008Blood75 citations Open access
Semantic Scholar
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study
F. Foss, N. Sjak-Shie, A. Goy, E. Jacobsen +5 more
2013Leukemia and Lymphoma69 citations
Semantic Scholar
Non-Hodgkin's lymphoma, leukemia, and exposures in agriculture: results from the Italian multicenter case-control study.
L. Miligi, A. S. Costantini, V. Bolejack, A. Veraldi +9 more
2003American Journal of Industrial Medicine68 citations
Semantic Scholar
Complete response in myeloma extends survival without, but not with history of prior monoclonal gammopathy of undetermined significance or smouldering disease
M. Pineda‐Roman, V. Bolejack, Varant Arzoumanian, E. Anaissie +9 more
2007British Journal of Haematology66 citations
Semantic Scholar
Immunotoxic effects of chemicals: A matrix for occupational and environmental epidemiological studies.
A. Veraldi, A. S. Costantini, V. Bolejack, L. Miligi +2 more
2006American Journal of Industrial Medicine65 citations Open access
Semantic Scholar
Phase II trial of vatalanib in patients with advanced or metastatic pancreatic adenocarcinoma after first-line gemcitabine therapy (PCRT O4-001)
T. Dragovich, D. Laheru, F. Dayyani, V. Bolejack +10 more
2014Cancer Chemotherapy and Pharmacology64 citations Open access
Semantic Scholar
A phase II study of vismodegib, a hedgehog (Hh) pathway inhibitor, combined with gemcitabine and nab-paclitaxel (nab-P) in patients (pts) with untreated metastatic pancreatic ductal adenocarcinoma (PDA).
A. De Jesus-Acosta, P. O'Dwyer, R. Ramanathan, D. V. Von Hoff +9 more
201457 citations
Semantic Scholar
Velcade (V)-Thalidomide (T)-Dexamethasone (D) for Advanced and Refractory Multiple Myeloma (MM): Long-Term Follow-Up of Phase I–II Trial UARK 2001-37: Superior Outcome in Patients with Normal Cytogenetics and No Prior T.
M. Zangari, B. Barlogie, M. Burns, V. Bolejack +5 more
200554 citations
Semantic Scholar
The New Tumor, Node, and Metastasis Staging System
Ramón Rami-Porta, V. Bolejack, Peter Goldstraw
2011Seminars in Respiratory and Critical Care Medicine47 citations
Semantic Scholar
A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results
S. Attia, V. Bolejack, K. Ganjoo, S. George +12 more
2022Cancer Medicine45 citations Open access
Semantic Scholar
Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma
V. Hungria, Â. Maiolino, G. Martinez, G. Colleoni +15 more
2008Haematologica42 citations Open access
Semantic Scholar
Multicenter phase II study of pembrolizumab (P) in advanced soft tissue (STS) and bone sarcomas (BS): Final results of SARC028 and biomarker analyses.
M. Burgess, V. Bolejack, B. Van Tine, S. Schuetze +16 more
201736 citations
Semantic Scholar
A randomized Southwest Oncology Group study comparing dexamethasone (D) to lenalidomide + dexamethasone (LD) as treatment of newly-diagnosed multiple myeloma (NDMM): Impact of cytogenetic abnormalities on efficacy of LD, and updated overall study results
J. Zonder, J. Crowley, V. Bolejack, M. Hussein +5 more
200834 citations
Semantic Scholar
A phase II trial of regorafenib (REGO) in patients (pts) with advanced Ewing sarcoma and related tumors (EWS) of soft tissue and bone: SARC024 trial results.
S. Attia, V. Bolejack, K. Ganjoo, S. George +12 more
201732 citations
Semantic Scholar
Prognostic factor analyses of myeloma survival with intergroup trial S9321 (INT 0141): examining whether different variables govern different time segments of survival
B. Barlogie, V. Bolejack, M. Schell, J. Crowley
2010Annals of Hematology31 citations Open access
Semantic Scholar
Association of Dasatinib With Progression-Free Survival Among Patients With Advanced Gastrointestinal Stromal Tumors Resistant to Imatinib
S. Schuetze, V. Bolejack, Dafydd Thomas, M. von Mehren +15 more
2018JAMA Oncology30 citations Open access
Semantic Scholar
Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapies.
R. Govindan, J. Crowley, L. Schwartzberg, P. Kennedy +6 more
2006Journal of Clinical Oncology30 citations
Semantic Scholar
Effect on survival of treatment-associated venous thromboembolism in newly diagnosed multiple myeloma patients
M. Zangari, B. Barlogie, F. Cavallo, V. Bolejack +2 more
2007Blood Coagulation and Fibrinolysis29 citations
Semantic Scholar
Phase II study of thalidomide plus dexamethasone induction followed by tandem melphalan-based autotransplantation and thalidomide-plus-prednisone maintenance for untreated multiple myeloma: a southwest oncology group trial (S0204).
M. Hussein, V. Bolejack, J. Zonder, B. Durie +3 more
2009Journal of Clinical Oncology27 citations Open access
Semantic Scholar
Response to Early Treatment Evaluated with 18F-FDG PET and PERCIST 1.0 Predicts Survival in Patients with Ewing Sarcoma Family of Tumors Treated with a Monoclonal Antibody to the Insulinlike Growth Factor 1 Receptor
Joo Hyun O, Brandon S. Luber, J. Leal, Hao Wang +7 more
2016Journal of Nuclear Medicine25 citations Open access
Semantic Scholar
Prognostic factors and jaw and renal complications among multiple myeloma patients treated with zoledronic acid
J. Berenson, O. Yellin, J. Crowley, A. Makary +15 more
2011American journal of hematology/oncology23 citations
Semantic Scholar
Superior 12-year survival after at least 4-year continuous remission with tandem transplantations for multiple myeloma.
B. Barlogie, M. Zangari, V. Bolejack, K. Hollmig +6 more
2006Clinical Lymphoma & Myeloma18 citations
Semantic Scholar
Assessment of Imaging Modalities and Response Metrics in Ewing Sarcoma: Correlation With Survival.
V. Koshkin, V. Bolejack, L. Schwartz, R. Wahl +7 more
2016Journal of Clinical Oncology17 citations Open access
Semantic Scholar
Denileukin Diftitox (ONTAK) Plus CHOP Chemotherapy in Patients with Peripheral T-Cell Lymphomas (PTCL), the CONCEPT Trial.
F. Foss, N. Sjak-Shie, A. Goy, E. Jacobsen +7 more
200717 citations
Semantic Scholar
High‐dose melphalan‐based autotransplants for multiple myeloma
M. Pineda‐Roman, B. Barlogie, E. Anaissie, M. Zangari +4 more
2008Cancer14 citations Open access
Semantic Scholar
Reply to "Inclusion of Lymphangitis as a Descriptor in the New TNM Staging of Lung Cancer: Filling Up the Blank Spaces".
R. Rami-Porta, V. Bolejack
2015Journal of Thoracic Oncology10 citations Open access
Semantic Scholar
Phase II trial of vatalinib in patients with advanced or metastatic pancreatic adenocarcinoma who failed gemcitabine therapy
T. Dragovich, D. Laheru, J. Crowley, L. Smith +6 more
20088 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Crowley×15
Invite
J. Crowley — researcher profile on SciRah
B. Barlogie×15
Invite
B. Barlogie — researcher profile on SciRah
D. Reinke×12
Invite
D. Reinke — researcher profile on SciRah
J. Crowley×10
Invite
J. Crowley — researcher profile on SciRah

×9

Invite

S. Schuetze — researcher profile on SciRah

Invite

S. Okuno — researcher profile on SciRah

Invite

S. Attia — researcher profile on SciRah

Invite

R. Riedel — researcher profile on SciRah

Lara E. Davis×7

Invite

Lara E. Davis — researcher profile on SciRah

Invite

L. Baker — researcher profile on SciRah

Invite

F. van Rhee — researcher profile on SciRah

Invite

M. Zangari — researcher profile on SciRah